2,879
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Different Relationships between FENO and COPD Characteristics in Smokers and Ex-Smokers

, , , , , , & show all
Pages 227-233 | Received 20 Feb 2019, Accepted 26 Jun 2019, Published online: 29 Jul 2019

References

  • Munakata M. Exhaled nitric oxide (FeNO) as a non-invasive marker of airway inflammation. Allergol Int. 2012;61:365–372. doi:10.2332/allergolint.12-RAI-0461.
  • Fahy JV. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol. 2015;15:57–65. doi:10.1038/nri3786.
  • Petsky HL, Kew KM, Chang AB. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev. 2016;11:CD011439. doi:10.1002/14651858.CD011439.pub2.
  • Normansell R, Cates C. Tailoring asthma therapies using FeNO: can a new objective measure help more people to gain control and reduce over-treatment? Cochrane Database Syst Rev. 2016;9:ED000115.
  • Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088–1098. doi:10.1056/NEJMoa1106469.
  • ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;171:912–930. https://www.atsjournals.org/doi/full/10.1164/rccm.200406-710ST?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed
  • Horvath I, Barnes PJ, Loukides S, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49:1600965. doi:10.1183/13993003.00965-2016.
  • Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–615. doi:10.1164/rccm.9120-11ST.
  • Mostafavi-Pour-Manshadi S-M-Y, Naderi N, Barrecheguren M, et al. Investigating fractional exhaled nitric oxide in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review. COPD. 2018;15:377–391. doi:10.1080/15412555.2018.1485637.
  • Malinovschi A, Janson C, Holmkvist T, et al. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J. 2006;28:339–345. doi:10.1183/09031936.06.00113705.
  • Verleden GM, Dupont LJ, Verpeut AC, et al. The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naive asthmatics. Chest. 1999;116:59–64. doi:10.1378/chest.116.1.59.
  • Lehouck A, Carremans C, De Bent K, et al. Alveolar and bronchial exhaled nitric oxide in chronic obstructive pulmonary disease. Resp Med. 2010;104:1020–1026. doi:10.1016/j.rmed.2010.01.001.
  • Río Ramírez MT, Juretschke Moragues MA, Fernández González R, et al. Value of exhaled nitric oxide (FeNO) and eosinophilia during the exacerbations of chronic obstructive pulmonary disease requiring hospital admission. COPD. 2018;15:369–376. doi:10.1080/15412555.2018.1482532.
  • Williamson PA, Menzies D, Clearie KL, et al. Dose-response for inhaled fluticasone on airway and systemic inflammation in COPD. Eur Respir J. 2011;37:206–209. doi:10.1183/09031936.00062210.
  • Takayama Y, Ohnishi H, Ogasawara F, et al. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap. COPD. 2018;13:2525–2532. doi:10.2147/COPD.S167600.
  • Shi F, Qiu C, Yu J, et al. Comparison of fractional exhaled nitric oxide in elderly patients with asthma-chronic obstructive pulmonary disease overlap and other airway inflammatory diseases. Iran J Allergy Asthma Immunol. 2018;17:232–239.
  • Colak Y, Afzal S, Nordestgaard BG, et al. Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study. Eur Respir J. 2018;52:1800616. doi:10.1183/13993003.00616-2018.
  • Malinovschi A, Janson C, Holmkvist T, et al. IgE sensitisation in relation to flow-independent nitric oxide exchange parameters. Respir Res. 2006;7:92. doi:10.1186/1465-9921-7-92.
  • Al-Shamkhi N, Alving K, Dahlen SE, et al. Important non-disease-related determinants of exhaled nitric oxide levels in mild asthma - results from the Swedish GA(2) LEN study. Clin Exp Allergy. 2016;6:1185–1193. doi:10.1111/cea.12749.
  • Kobayashi S, Hanagama M, Yamanda S, et al. Inflammatory biomarkers in asthma-COPD overlap syndrome. COPD. 2016;11: 2117–23. doi:10.2147/COPD.S113647.
  • Högman M, Sulku J, Ställberg B, et al. 2017 Global initiative for chronic obstructive lung disease reclassifies half of COPD subjects to lower risk group. COPD. 2018;13:165–173. doi:10.2147/COPD.S151016.
  • Hedenström H, Malmberg P, Agarwal K. Reference values for lung function tests in female. Regression equations with smoking variables. Bull Eur Physiopathol Respir. 1985;21:551–557.
  • Hedenström H, Malmberg P, Fridriksson HV. Reference values for pulmonary function test in men: regression equations which include tobacco smoking variables. Upsala J Med Sci. 1986;91:299–310. doi:10.3109/03009738609178670.
  • Högman M, Lúdvı́ksdóttir D, Anderson SD, et al. Inhaled mannitol shifts exhaled nitric oxide in opposite directions in asthmatics and healthy subjects. Respir Physiol. 2001;124:141–150. doi:10.1016/S0034-5687(00)00195-X.
  • Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53:91–95. doi:10.1136/thx.53.2.91.
  • Berry MA, Shaw DE, Green RH, et al. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy. 2005;35:1175. doi:10.1111/j.1365-2222.2005.02314.x.
  • Soter S, Barta I, Antus B. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide. Inflammation. 2013;36:1178–1185. doi:10.1007/s10753-013-9653-8.
  • Tomlinson JEM, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax. 2005;60:282–287. doi:10.1136/thx.2004.033688.
  • Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41:716–726. doi:10.1183/09031936.00073312.
  • Bourbeau J, Christodoulopoulos P, Maltais F, et al. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax. 2007;62:938–943. doi:10.1136/thx.2006.071068.
  • Krantz C, Janson C, Hollsing A, et al. Exhaled and nasal nitric oxide in relation to lung function, blood cell counts and disease characteristics in cystic fibrosis. J Breath Res. 2017;11:026001. doi:10.1088/1752-7163/aa61aa.
  • Jones KL, Bryan TW, Jinkins PA, et al. Superoxide released from neutrophils causes a reduction in nitric oxide gas. Am J Physiol. 1998;275:L1120–6. doi:10.1152/ajplung.1998.275.6.L1120.
  • Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359:2355–2365. doi:10.1056/NEJMra0800353.
  • Acosta N, Heirali A, Somayaji R, et al. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis. Thorax. 2018;73:1016–1025. doi:10.1136/thoraxjnl-2018-211510.
  • Ricciardolo F. Multiple roles of nitric oxide in the airways. Thorax. 2003;58:175–182. doi:10.1136/thorax.58.2.175.
  • Ricciardolo FLM, Sterk PJ, Gaston B, et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004;84:731–765. doi:10.1152/physrev.00034.2003.
  • Högman M, Thornadtsson A, Liv P, et al. Effects of growth and aging on the reference values of pulmonary nitric oxide dynamics in healthy subjects. J Breath Res. 2017;11:047103. doi:10.1088/1752-7163/aa7957.
  • Bożek A, Rogala B. IgE-dependent sensitization in patients with COPD. Ann Agric Environ Med. 2018;25:417–420. doi:10.26444/aaem/83413.
  • Tamada T, Sugiura H, Takahashi T. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015;10:2169–2176.
  • Olin A-C, Rosengren A, Thelle DS, et al. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest. 2006;130:1319–1325. doi:10.1378/chest.130.5.1319.
  • Jacinto T, Malinovschi A, Janson C, et al. Evolution of exhaled nitric oxide levels throughout development and aging of healthy humans. J Breath Res. 2015;9:036005. doi:10.1088/1752-7155/9/3/036005.
  • Antus B, Horvath I, Barta I. Assessment of exhaled nitric oxide by a new hand-held device. Respir Med. 2010;104:1377–1380. doi:10.1016/j.rmed.2010.06.005.